Accuray Incorporated (NASDAQ:ARAY) Shares Acquired by North Star Investment Management Corp.

North Star Investment Management Corp. boosted its stake in Accuray Incorporated (NASDAQ:ARAY) by 1.0% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,058,545 shares of the medical equipment provider’s stock after buying an additional 10,000 shares during the period. North Star Investment Management Corp. owned 1.03% of Accuray worth $1,895,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of ARAY. Heartland Advisors Inc. boosted its stake in Accuray by 14.1% during the fourth quarter. Heartland Advisors Inc. now owns 3,824,750 shares of the medical equipment provider’s stock valued at $7,573,000 after buying an additional 472,800 shares in the last quarter. Renaissance Technologies LLC lifted its holdings in Accuray by 6.8% in the 4th quarter. Renaissance Technologies LLC now owns 2,979,998 shares of the medical equipment provider’s stock valued at $5,900,000 after acquiring an additional 189,414 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Accuray by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 2,186,154 shares of the medical equipment provider’s stock valued at $4,329,000 after purchasing an additional 6,758 shares in the last quarter. D. E. Shaw & Co. Inc. grew its stake in shares of Accuray by 5.4% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 1,793,391 shares of the medical equipment provider’s stock worth $3,551,000 after purchasing an additional 91,529 shares during the last quarter. Finally, Archon Capital Management LLC raised its holdings in shares of Accuray by 11.5% in the 4th quarter. Archon Capital Management LLC now owns 888,662 shares of the medical equipment provider’s stock worth $1,760,000 after purchasing an additional 91,796 shares in the last quarter. Institutional investors and hedge funds own 64.08% of the company’s stock.

Accuray Stock Performance

Shares of NASDAQ ARAY opened at $1.22 on Monday. The stock’s fifty day simple moving average is $1.50 and its 200 day simple moving average is $1.85. The stock has a market capitalization of $125.68 million, a price-to-earnings ratio of -24.40 and a beta of 1.30. The company has a quick ratio of 0.88, a current ratio of 1.62 and a debt-to-equity ratio of 3.51. Accuray Incorporated has a 52-week low of $1.14 and a 52-week high of $2.95.

Accuray (NASDAQ:ARAY) last issued its quarterly earnings results on Wednesday, April 30th. The medical equipment provider reported ($0.01) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.04. Accuray had a negative return on equity of 9.75% and a negative net margin of 0.96%. The firm had revenue of $113.24 million for the quarter, compared to analysts’ expectations of $101.53 million. As a group, sell-side analysts forecast that Accuray Incorporated will post 0.01 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, Wall Street Zen upgraded shares of Accuray from a “hold” rating to a “buy” rating in a report on Friday, May 30th.

About Accuray

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate.